RHBDD1 and malignant colon neoplasm: Also, miR-145-5p overexpression was shown to downregulate RHBDD1 by inhibiting EGFR-related signaling pathways (EGFR/Raf/MEK/ERK axis), thereby inhibiting colon cancer tumorigenesis [33].